Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
Simone I. Richardson, Vimbai Sharon Madzorera, Holly Spencer, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 880-886.e4
Open Access | Times Cited: 105

Showing 26-50 of 105 citing articles:

SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
Adam Abdullahi, David Oladele, Michael Owusu, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
A spike-trimer protein-based tetravalent COVID-19 vaccine elicits enhanced breadth of neutralization against SARS-CoV-2 Omicron subvariants and other variants
Rui Wang, Hongpeng Huang, Chulin Yu, et al.
Science China Life Sciences (2022) Vol. 66, Iss. 8, pp. 1818-1830
Open Access | Times Cited: 24
Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
Giorgio Tiecco, Samuele Storti, Stefania Arsuffi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7315-7315
Open Access | Times Cited: 22
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer
Annika Fendler, Scott T.C. Shepherd, Lewis Au, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 10, pp. 100781-100781
Open Access | Times Cited: 22
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
Shô Miyamoto, Takeshi Arashiro, Akira Ueno, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105969-105969
Open Access | Times Cited: 12
Specific long‐term changes in anti‐SARS‐CoV‐2 IgG modifications and antibody functions in mRNA, adenovector, and protein subunit vaccines
Sebastian Reinig, Chin Hwa Kuo, Chia‐Chun Wu, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 7
Open Access | Times Cited: 4
Immunoglobulin replacement products confer in vivo protection against SARS-CoV-2 XBB.1.5 Omicron variant despite poor neutralizing activity
Ofer Zimmerman, Alexa Michelle Altman Doss, Baoling Ying, et al.
JCI Insight (2024)
Open Access | Times Cited: 3
Recurring SARS-CoV-2 variants: an update on post-pandemic, co-infections and immune response
Ashmit Verma, Anjali Manojkumar, Anupam Dhasmana, et al.
Nanotheranostics (2024) Vol. 8, Iss. 2, pp. 247-269
Open Access | Times Cited: 3
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants
Catherine Riou, Jinal N. Bhiman, Yashica Ganga, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 4, pp. e0002703-e0002703
Open Access | Times Cited: 3
Hybrid Immunity Provides Protective Advantage Over Vaccination or Prior Remote Coronavirus Disease 2019 Alone
Abinash Virk, Matthew G. Johnson, Daniel Roellinger, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 5
Open Access | Times Cited: 9
Novavax NVX-COV2373 triggers potent neutralization of Omicron sub-lineages
Jinal N. Bhiman, Simone I. Richardson, Bronwen E. Lambson, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 14
SARS‐CoV‐2 spike trimer vaccine expressed in Nicotiana benthamiana adjuvanted with Alum elicits protective immune responses in mice
Shi‐Jian Song, Heeyeon Kim, Eun Young Jang, et al.
Plant Biotechnology Journal (2022) Vol. 20, Iss. 12, pp. 2298-2312
Open Access | Times Cited: 14
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant
Simone I. Richardson, Prudence Kgagudi, Nelia P. Manamela, et al.
Cell Reports Medicine (2022) Vol. 4, Iss. 1, pp. 100910-100910
Open Access | Times Cited: 14
Coronavac inactivated vaccine triggers durable, cross-reactive Fc-mediated phagocytosis activities
Lili Wang, Chuang Li, Wanting Li, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 8
Bivalent mRNA vaccine effectiveness against SARS-CoV-2 variants of concern
Monika Kumari, Shih-Chieh Su, Kang-Hao Liang, et al.
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 8
A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
David Niklas Springer, Marianna Traugott, Elisabeth Reuberger, et al.
Diagnostics (2023) Vol. 13, Iss. 13, pp. 2278-2278
Open Access | Times Cited: 8
Broad and potent neutralizing antibodies are elicited in vaccinated individuals following Delta/BA.1 breakthrough infection
Jeffrey Seow, Zayed A. Shalim, Carl Graham, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 8
Non-neutralizing functions in anti-SARS-CoV-2 IgG antibodies
Sebastian Reinig, Shin‐Ru Shih
Biomedical Journal (2023) Vol. 47, Iss. 1, pp. 100666-100666
Open Access | Times Cited: 8
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants
Thandeka Moyo-Gwete, Mashudu Madzivhandila, Nonhlanhla N. Mkhize, et al.
Journal of Virology (2022) Vol. 96, Iss. 15
Open Access | Times Cited: 13
Reduced B cell antigenicity of Omicron lowers host serologic response
Jérôme Tubiana, Yufei Xiang, Li Fan, et al.
Cell Reports (2022) Vol. 41, Iss. 3, pp. 111512-111512
Open Access | Times Cited: 13
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concern
Carl Graham, Thomas Lechmere, Aisha Rehman, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 10, pp. e1010882-e1010882
Open Access | Times Cited: 13
SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
Maarten E. Emmelot, Martijn Vos, Mardi C. Boer, et al.
Viruses (2022) Vol. 15, Iss. 1, pp. 101-101
Open Access | Times Cited: 13
Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders
Douglas F. Lake, Alexa J. Roeder, María J. González‐Moa, et al.
Communications Medicine (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 12
Pre-Omicron Vaccine Breakthrough Infection Induces Superior Cross-Neutralization against SARS-CoV-2 Omicron BA.1 Compared to Infection Alone
Eveline Santos da Silva, Michel Kohnen, Georges Gilson, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7675-7675
Open Access | Times Cited: 12
COVID-19 vaccines and a perspective on Africa
Alberto Mantovani, María Rescigno, Guido Forni, et al.
Trends in Immunology (2023) Vol. 44, Iss. 3, pp. 172-187
Open Access | Times Cited: 7

Scroll to top